Immunotec Inc (IMMTF) 0.1900 $IMMTF
Immunotec Resolves Taxation Matters in Mexico
Marketwired - Tue Jul 21, 3:06PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, reports reaching a Conclusive Agreement ("the Agreement" with both tax authorities Procuraduria de la Defensa del Contribuyente ("PRODECON" and Servicio Administracion Tributaria ("SAT" in regard to the Company's Mexican subsidiary's imports into Mexico.
IMM.VN: 0.240 (-0.005)
Immunotec Obtains $2,780,000 of New Financing
Marketwired - Mon Jul 20, 3:06PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec", announces that it has obtained additional financing from the Toronto Dominion Bank ("TD Bank" and a new credit facility from Export Development Canada ("EDC".
IMM.VN: 0.240 (-0.005)
Immunotec Reports Issuance of Options
Marketwired - Wed Jun 17, 5:01PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec", today announced that pursuant to the Immunotec Stock Option Plan, a group of directors, officers, managers and a consultant were granted options entitling them to acquire, in the aggregate, up to 1,000,000 common shares of the Company (the "Shares". The exercise price of such options was established at $0.30, which is the closing price of the Shares on the TSX Venture Exchange the day before their issuance. These options will vest over a three-year period, with one-third (1/3) which will vest on each of the first, second and third anniversaries of the date of the grant. Each option is exercisable, once vested, for a period of five years from the date of grant.
IMM.VN: 0.240 (-0.005)
Immunotec Reports Second Quarter Results
Marketwired - Fri Jun 12, 4:45PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec", today announced its consolidated financial results for the second quarter of Fiscal 2015. All amounts in this press release are denominated in Canadian dollars unless otherwise indicated.
IMM.VN: 0.240 (-0.005)
Immunocal(R) First to be Granted Strength and Performance Claim for a Stand-Alone Whey Protein by Health Canada
Marketwired - Tue May 12, 8:03AM CDT
Immunotec Inc. (TSX VENTURE: IMM) a direct-to-consumer company and leader in the nutritional industry (the "Company" or "Immunotec" announced today that Health Canada has granted a new health claim specific to Immunocal's ability to help increase muscle strength and enhance performance when combined with regular exercise.
IMM.VN: 0.240 (-0.005)
Immunotec Ranks No. 97 in Sixth Annual DSN Global 100
Marketwired - Mon Apr 20, 3:01PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry has been ranked 97th on the Direct Selling News sixth annual DSN Global 100 list. This list is an exclusive ranking of the top revenue-generating companies in the direct selling industry worldwide.
IMM.VN: 0.240 (-0.005)
Herbalife: The Eve Of Destruction
Rogier van Vlissingen - at Seeking Alpha - Thu Mar 26, 11:14AM CDT
HLF: 56.02 (-0.18), AVP: 3.48 (-0.62), NUS: 43.77 (+0.09), LFVN: 0.79 (+0.03)
Immunotec Reports Results of its Annual General and Special Meeting of Shareholders
Marketwired - Fri Mar 20, 3:19PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec", today reported the results of its Annual General and Special Meeting of Shareholders held on March 17, 2015 ("AGM". During the AGM, all current directors of the Company were re-elected, PricewaterhouseCoopers LLP was reappointed as the Company's auditor and the new Management Incentive Plan ("MIP" announced on February 18, 2015 was approved by disinterested shareholders. Three million common shares of the Company (the "Shares" are reserved and authorized for future issuance under this MIP. The full text of the MIP appears in the Company's Management Proxy Circular filed on February 19, 2015 on SEDAR and may be consulted at www.sedar.com.
IMM.VN: 0.240 (-0.005)
Immunotec Reports First Quarter Results
Marketwired - Tue Mar 17, 3:01PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec", today announced its consolidated financial results for the first quarter of Fiscal 2015. All amounts in this press release are denominated in Canadian dollars unless otherwise indicated.
IMM.VN: 0.240 (-0.005)
Immunotec Announces Proposed Management Incentive Plan
Marketwired - Wed Feb 18, 3:49PM CST
Immunotec Inc. (TSX VENTURE: IMM), a direct- to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec", today announced the terms of its new Management Incentive Plan ("MIP". This MIP will be submitted to the Company's shareholders for approval at the upcoming Annual and Special Meeting of Shareholders to be held on March 17, 2015.
IMM.VN: 0.240 (-0.005)
Immunotec Is Not Immune To Taxes
Duane Bair - at Seeking Alpha - Thu Feb 05, 7:23AM CST
Immunotec Resolves Taxation Matters in Mexico
Marketwired - Tue Jul 21, 3:06PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, reports reaching a Conclusive Agreement ("the Agreement" with both tax authorities Procuraduria de la Defensa del Contribuyente ("PRODECON" and Servicio Administracion Tributaria ("SAT" in regard to the Company's Mexican subsidiary's imports into Mexico. IMM.VN: 0.240 (-0.005)
Immunotec Obtains $2,780,000 of New Financing
Marketwired - Mon Jul 20, 3:06PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, announces that it has obtained additional financing from the Toronto Dominion Bank ("TD Bank" and a new credit facility from Export Development Canada ("EDC". IMM.VN: 0.240 (-0.005)
Immunotec Reports Issuance of Options
Marketwired - Wed Jun 17, 5:01PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, today announced that pursuant to the Immunotec Stock Option Plan, a group of directors, officers, managers and a consultant were granted options entitling them to acquire, in the aggregate, up to 1,000,000 common shares of the Company (the "Shares". The exercise price of such options was established at $0.30, which is the closing price of the Shares on the TSX Venture Exchange the day before their issuance. These options will vest over a three-year period, with one-third (1/3) which will vest on each of the first, second and third anniversaries of the date of the grant. Each option is exercisable, once vested, for a period of five years from the date of grant. IMM.VN: 0.240 (-0.005)
Immunotec Reports Second Quarter Results
Marketwired - Fri Jun 12, 4:45PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, today announced its consolidated financial results for the second quarter of Fiscal 2015. All amounts in this press release are denominated in Canadian dollars unless otherwise indicated. IMM.VN: 0.240 (-0.005)
Immunocal(R) First to be Granted Strength and Performance Claim for a Stand-Alone Whey Protein by Health Canada
Marketwired - Tue May 12, 8:03AM CDT
Immunotec Inc. (TSX VENTURE: IMM) a direct-to-consumer company and leader in the nutritional industry (the "Company" or "Immunotec"
announced today that Health Canada has granted a new health claim specific to Immunocal's ability to help increase muscle strength and enhance performance when combined with regular exercise. IMM.VN: 0.240 (-0.005)
Immunotec Ranks No. 97 in Sixth Annual DSN Global 100
Marketwired - Mon Apr 20, 3:01PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry has been ranked 97th on the Direct Selling News sixth annual DSN Global 100 list. This list is an exclusive ranking of the top revenue-generating companies in the direct selling industry worldwide.
IMM.VN: 0.240 (-0.005)
Herbalife: The Eve Of Destruction
Rogier van Vlissingen - at Seeking Alpha - Thu Mar 26, 11:14AM CDT
HLF: 56.02 (-0.18), AVP: 3.48 (-0.62), NUS: 43.77 (+0.09), LFVN: 0.79 (+0.03)
Immunotec Reports Results of its Annual General and Special Meeting of Shareholders
Marketwired - Fri Mar 20, 3:19PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, today reported the results of its Annual General and Special Meeting of Shareholders held on March 17, 2015 ("AGM". During the AGM, all current directors of the Company were re-elected, PricewaterhouseCoopers LLP was reappointed as the Company's auditor and the new Management Incentive Plan ("MIP" announced on February 18, 2015 was approved by disinterested shareholders. Three million common shares of the Company (the "Shares" are reserved and authorized for future issuance under this MIP. The full text of the MIP appears in the Company's Management Proxy Circular filed on February 19, 2015 on SEDAR and may be consulted at www.sedar.com. IMM.VN: 0.240 (-0.005)
Immunotec Reports First Quarter Results
Marketwired - Tue Mar 17, 3:01PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, today announced its consolidated financial results for the first quarter of Fiscal 2015. All amounts in this press release are denominated in Canadian dollars unless otherwise indicated. IMM.VN: 0.240 (-0.005)
Immunotec Announces Proposed Management Incentive Plan
Marketwired - Wed Feb 18, 3:49PM CST
Immunotec Inc. (TSX VENTURE: IMM), a direct- to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, today announced the terms of its new Management Incentive Plan ("MIP". This MIP will be submitted to the Company's shareholders for approval at the upcoming Annual and Special Meeting of Shareholders to be held on March 17, 2015. IMM.VN: 0.240 (-0.005)
Immunotec Is Not Immune To Taxes
Duane Bair - at Seeking Alpha - Thu Feb 05, 7:23AM CST
